Olimmune

Olimmune is an immunotherapy company that has created a new category of bispecific oligonucleotide therapies designed to target dormant immune cells in the tumor microenvironment. Activating these antigen-presenting cells removes the immunosuppressive barrier around the tumor and initiates a T cell-mediated immune response to kill cancer cells.